Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MREO |
---|---|---|
09:32 ET | 3037 | 2.6701 |
09:34 ET | 2500 | 2.6899 |
09:36 ET | 4457 | 2.7566 |
09:38 ET | 150 | 2.755 |
09:41 ET | 100 | 2.745 |
09:45 ET | 210 | 2.7402 |
09:48 ET | 700 | 2.74 |
09:52 ET | 200 | 2.73 |
09:54 ET | 1800 | 2.73 |
09:56 ET | 100 | 2.725 |
09:59 ET | 8908 | 2.71 |
10:01 ET | 200 | 2.7167 |
10:03 ET | 600 | 2.725 |
10:08 ET | 2028 | 2.745 |
10:10 ET | 1900 | 2.74 |
10:12 ET | 850 | 2.74 |
10:14 ET | 300 | 2.725 |
10:15 ET | 2836 | 2.721 |
10:17 ET | 668 | 2.7289 |
10:19 ET | 400 | 2.725 |
10:21 ET | 23413 | 2.7 |
10:24 ET | 100 | 2.705 |
10:26 ET | 4792 | 2.7 |
10:28 ET | 2430 | 2.7 |
10:30 ET | 600 | 2.695 |
10:32 ET | 800 | 2.7 |
10:33 ET | 2645 | 2.71 |
10:35 ET | 400 | 2.71 |
10:39 ET | 9699 | 2.73 |
10:44 ET | 4265 | 2.71 |
10:46 ET | 21433 | 2.75 |
10:48 ET | 1611 | 2.75 |
10:51 ET | 1200 | 2.75 |
10:53 ET | 2000 | 2.7514 |
10:55 ET | 978 | 2.7579 |
10:57 ET | 400 | 2.75 |
11:00 ET | 9813 | 2.76 |
11:04 ET | 634 | 2.76 |
11:06 ET | 905 | 2.7618 |
11:09 ET | 258 | 2.765 |
11:20 ET | 3790 | 2.765 |
11:24 ET | 958 | 2.77 |
11:27 ET | 400 | 2.76 |
11:36 ET | 4316 | 2.7699 |
11:42 ET | 699 | 2.76 |
11:44 ET | 100 | 2.765 |
11:45 ET | 9401 | 2.785 |
11:47 ET | 567 | 2.79 |
11:49 ET | 1490 | 2.795 |
11:51 ET | 200 | 2.8 |
11:54 ET | 1000 | 2.795 |
11:56 ET | 758 | 2.795 |
11:58 ET | 1824 | 2.8 |
12:00 ET | 1058 | 2.8 |
12:02 ET | 5224 | 2.8 |
12:03 ET | 600 | 2.8 |
12:05 ET | 21870 | 2.77 |
12:07 ET | 2350 | 2.765 |
12:09 ET | 3282 | 2.75 |
12:12 ET | 1847 | 2.75 |
12:14 ET | 2534 | 2.755 |
12:16 ET | 3058 | 2.755 |
12:18 ET | 1482 | 2.75 |
12:20 ET | 1300 | 2.755 |
12:21 ET | 200 | 2.755 |
12:23 ET | 1300 | 2.75 |
12:25 ET | 351 | 2.7491 |
12:27 ET | 1000 | 2.75 |
12:30 ET | 1001 | 2.75 |
12:32 ET | 6867 | 2.749 |
12:34 ET | 100 | 2.75 |
12:36 ET | 4674 | 2.77 |
12:38 ET | 200 | 2.77 |
12:39 ET | 400 | 2.77 |
12:41 ET | 200 | 2.765 |
12:43 ET | 200 | 2.765 |
12:45 ET | 2465 | 2.775 |
12:48 ET | 650 | 2.775 |
12:50 ET | 400 | 2.775 |
12:52 ET | 1300 | 2.7747 |
12:54 ET | 500 | 2.775 |
12:56 ET | 1978 | 2.78 |
12:57 ET | 9686 | 2.79 |
12:59 ET | 100 | 2.785 |
01:01 ET | 1019 | 2.78 |
01:03 ET | 400 | 2.785 |
01:06 ET | 300 | 2.785 |
01:08 ET | 4126 | 2.795 |
01:10 ET | 3511 | 2.8 |
01:12 ET | 100 | 2.8047 |
01:15 ET | 22384 | 2.8 |
01:17 ET | 9355 | 2.81 |
01:21 ET | 1000 | 2.805 |
01:32 ET | 1300 | 2.8 |
01:35 ET | 200 | 2.795 |
01:37 ET | 400 | 2.795 |
01:39 ET | 200 | 2.8 |
01:42 ET | 400 | 2.795 |
01:46 ET | 2300 | 2.795 |
01:48 ET | 150 | 2.7978 |
01:50 ET | 1847 | 2.8015 |
01:53 ET | 1000 | 2.805 |
02:04 ET | 200 | 2.8099 |
02:06 ET | 2635 | 2.8 |
02:08 ET | 1900 | 2.8 |
02:13 ET | 300 | 2.8 |
02:15 ET | 362 | 2.8 |
02:18 ET | 730 | 2.8 |
02:20 ET | 7829 | 2.805 |
02:22 ET | 950 | 2.805 |
02:26 ET | 500 | 2.8029 |
02:33 ET | 3276 | 2.805 |
02:38 ET | 250 | 2.801 |
02:40 ET | 107 | 2.807 |
02:45 ET | 11522 | 2.805 |
02:47 ET | 13382 | 2.78 |
02:49 ET | 985 | 2.785 |
02:51 ET | 400 | 2.785 |
02:54 ET | 600 | 2.785 |
02:56 ET | 4528 | 2.8 |
02:58 ET | 200 | 2.8 |
03:00 ET | 598 | 2.8 |
03:02 ET | 5024 | 2.785 |
03:03 ET | 2518 | 2.775 |
03:05 ET | 6000 | 2.775 |
03:07 ET | 7848 | 2.775 |
03:09 ET | 429 | 2.78 |
03:12 ET | 3455 | 2.79 |
03:14 ET | 400 | 2.79 |
03:16 ET | 500 | 2.79 |
03:18 ET | 700 | 2.79 |
03:20 ET | 1407 | 2.795 |
03:21 ET | 641 | 2.8 |
03:23 ET | 2100 | 2.8 |
03:25 ET | 1199 | 2.8 |
03:27 ET | 1000 | 2.8 |
03:30 ET | 300 | 2.8 |
03:32 ET | 100 | 2.8 |
03:34 ET | 1150 | 2.8 |
03:36 ET | 6545 | 2.79 |
03:38 ET | 200 | 2.79 |
03:39 ET | 1100 | 2.785 |
03:41 ET | 2750 | 2.79 |
03:43 ET | 800 | 2.785 |
03:45 ET | 8955 | 2.79 |
03:48 ET | 4100 | 2.785 |
03:50 ET | 4936 | 2.775 |
03:52 ET | 8200 | 2.78 |
03:54 ET | 1836 | 2.78 |
03:56 ET | 3950 | 2.78 |
03:57 ET | 5400 | 2.78 |
03:59 ET | 69241 | 2.76 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Mereo BioPharma Group PLC | 387.1M | -10.5x | --- |
Allogene Therapeutics Inc | 484.9M | -1.4x | --- |
Nkarta Inc | 485.7M | -2.9x | --- |
Humacyte Inc | 487.1M | -3.8x | --- |
Celcuity Inc | 488.8M | -5.9x | --- |
Cabaletta Bio Inc | 490.5M | -6.3x | --- |
Mereo BioPharma Group plc is a biopharmaceutical company. It is focused on the development of therapeutics for rare diseases. It has developed a portfolio of clinical-stage product candidates. The Company has two rare disease product candidates: setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat for the treatment of severe alpha-1-antitrypsin deficiency-associated lung disease (AATD-LD) and bronchiolitis obliterans syndrome (BOS). It also has two oncology product candidates in clinical development. It also includes Etigilimab, an antibody against TIGIT (T-cell immunoreceptor with Ig and ITIM domains). Its non-core partnered programme, Navicixizumab, is a bispecific antibody that inhibits delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF). Its non-core programs available for partnership include Acumapimod and Leflutrozole. Acumapimod is a p38 MAP kinase inhibitor therapy for treatment during severe acute exacerbations of COPD (AECOPD).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $387.1M |
---|---|
Revenue (TTM) | $9.0M |
Shares Outstanding | 140.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.82 |
EPS | $-0.26 |
Book Value | $0.62 |
P/E Ratio | -10.5x |
Price/Sales (TTM) | 43.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -444.28% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.